PharmaBoardroom

Russia First Mover in Approving COVID-19 Vaccine Amid Widespread…

Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities, the first such approval globally.…

The Long Read: Belgium – The Multifaceted

Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical powerhouses of Germany and France,…

When Health Policy Becomes Industrial Policy

In his latest piece, Brendan Shaw casts his eye over why those drawing up health policies need to start incorporating issues of industrial policy into…

Six Trends in the Brazilian OTC Market Post-COVID-19

Panorama Faramceutico’s editorial team look at how the ongoing COVID-19 pandemic stands to affect Brazil’s over the counter (OTC) market segment…

Pharma Faces: Sonja Willems, Janssen Benelux

Belgium is a vitally important country for Johnson & Johnson's pharmaceutical arm, Janssen, globally. In addition to their R&D centre and a…

In Profile: Stéphane De Wit, A Pioneer in HIV Research

Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in Brussels since 1983. Initially planning…

Hospital Reform in Belgium: A Guarantee of Better Care?

Belgium’s healthcare system was ranked fourth in Europe in 2019, outperforming its peers across a number of metrics including a relatively high…

Overcoming US Pricing & Reimbursement Challenges

Executives from ALK, Sanofi Genzyme and Novartis discuss how they are navigating pricing and reimbursement issues in the USA, home to the world’s…

Hong Kong Biotech IPOs since Listing Reform in April 2018

On 30 April 2018, Hong Kong Stock Exchange’s (HKEX’s) introduced a number of reforms to allow and support the listing of pre-profit biotech…

US Execs on Product Launch Strategies during COVID-19: Digital…

With COVID-19 having wreaked havoc on global operations, the pharma industry is understandably focused on leveraging its collective resources and…

Understanding the Value of Patient Engagement

Jessica Scott, Takeda’s head of R&D patient engagement, highlights how a better understanding of the value of patient engagement across the…

Maintaining Open Innovation in Our ‘New Normal’ Through…

Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park explores new ways of virtual collaboration that make our lives easier while…

Sign in

Tagged with